Achieve Life Sciences Inc. (ACHV)
NASDAQ: ACHVHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
ACHV stock chart
Technical analysisKey statistics
All statistics- Market cap
- $746.46M
- EPS (TTM)
- -$1.69
- Dividend yield
- None
- 52-week range
- 2.62 – 8.64
- Day range
- 6.96 – 7.35
- Volume / Avg
- 1.04M / 1.46M
- Beta
- —
- Shares outstanding
- 103.10M
- Next earnings
- Nov 5, 2026
52-week range
ACHV stock today
Shares of Achieve Life Sciences (ACHV) finished higher on Oct 7 at $7.24, a gain of 2.99% or $0.21 per share, versus the S&P 500's 0.22% decline. At this level, ACHV sits in the middle of its 52-week range of $2.62 to $8.64: 16.2% below the high, set on Sep 3, 2026 and 176.3% above the low. ACHV is up 45.7% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 118.1%.
Achieve Life Sciences has posted a net loss over the last twelve months (EPS of -$1.69), so its P/E ratio is not meaningful. Achieve Life Sciences's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Achieve Life Sciences
Company profile- Sector
- Health Care
- Industry
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $-0.20
Achieve Life Sciences peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| QDELQuidelOrtho Corporation | 12.31 | -2.07% | $844.16M | vs ACHV |
| TKNOAlpha Teknova Inc. | 8.71 | -0.46% | $467.62M | vs ACHV |
| MYGNMyriad Genetics Inc. | 4.28 | 0.00% | $409.38M | vs ACHV |
| NNNNAnbio Biotechnology Class A | 4.90 | 0.00% | $215.07M | vs ACHV |
| IMDXInsight Molecular Diagnostics Inc. | 3.46 | +2.37% | $113.23M | vs ACHV |
| ICCCImmuCell Corporation | 9.69 | -2.81% | $88.01M | vs ACHV |
| BMRABiomerica Inc. | 1.91 | -10.75% | $8.78M | vs ACHV |
| VNRXVolitionRX Limited | 0.226 | -6.96% | $6.79M | vs ACHV |
Indexes, lists and sector
Achieve Life Sciences stock FAQ
What is Achieve Life Sciences's stock price today?
ACHV last traded at $7.24 as of Oct 7, 4:00 PM EDT, up 2.99% on the day. Prices are delayed at least 15 minutes.
Does Achieve Life Sciences pay a dividend?
No. Achieve Life Sciences does not currently pay a regular cash dividend.
When is Achieve Life Sciences's next earnings date?
Achieve Life Sciences is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $-0.20.
Has ACHV ever split its stock?
Yes. The most recent ACHV stock split was a 1-for-20 split on Jul 31, 2020, one of 4 splits on record.
What is the ACHV 52-week high?
The 52-week high for ACHV is $8.64 and the 52-week low is $2.62. The stock is currently 16.2% below its high.